Outcomes Engine

Adherence & Cohort Analytics

Medication possession ratio, HbA1c trajectory and persistence — the evidence layer behind the programme's commercial story.

Optimal

Adherent Cohort

MPR ≥ 0.85 · ≥10 refills/12mo

51.0%

15,851 patients

Mean HbA1c7.1%

Δ from baseline−2.1 pp

Partial

Partially Adherent

MPR 0.60 – 0.84

31.0%

9,632 patients

Mean HbA1c7.9%

Δ from baseline−1.2 pp

At-risk

Lapsing Cohort

MPR 0.40 – 0.59 · 1+ gap

14.0%

4,351 patients

Mean HbA1c9.0%

Coach contact rate92%

Discontinued

No refill 60d+ / opt-out

7.0%

2,586 patients

Re-engaged 30d11.4%

Industry mean38%

Persistence curve — Kaplan-Meier

Probability of remaining on therapy, days from initiation

Publication-grade

Care+ enrolled · 95% CI Matched control (unsupported)

Log-rank p < 0.001 · HR for discontinuation 0.34 (95% CI 0.31–0.37)

Discontinuation drivers

Reasons captured at opt-out · n=2,586

Cost / affordability

31%

Side effects (hypo, GI)

24%

Switched to other therapy

18%

Travelled / lost to follow-up

12%

Felt better / stopped

Other / not captured

Drill into cost-driven cohort →

Coach intervention outcomes

Re-engagement and adherence recovery by intervention type (last 90 days)

Intervention type	Trigger	Patients	Reached	Re-engaged 30d	MPR uplift	HbA1c effect	Cost / outcome
Refill-lapse outreach Voice + WhatsApp	Refill gap ≥14d	3,840	3,512	62%	+0.18	−0.7%	₹ 142
Titration support Nurse call + visual guide	Insulin dose change	2,148	2,068	88%	+0.24	−1.2%	₹ 198
Side-effect counselling Coach + escalation	Symptom report	912	894	71%	+0.21	−0.9%	₹ 312
Lifestyle nudge series App content + coach check-in	Enrolled cohort	12,840	11,212	—	+0.09	−0.4%	₹ 64
HbA1c reminder Lab booking + result handoff	90d cadence	8,420	7,128	—	—	tracked	₹ 88

Weighted programme cost-per-outcome (HbA1c < 7%): ₹ 1,847 View attribution methodology →

HbA1c trajectory by adherence cohort

12-month follow-up, paired measurements

Adherent cohort · 9.4% → 7.1% Partially adherent · 9.3% → 7.9% At-risk · 9.3% → 9.0% Discontinued · 9.3% → 10.2% (last available)